Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 45 in last 24h · 115,255 total before filter · latest 1h ago
45last 24h
1803last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings851M&A104Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance
Simply Wall St.1d agoneutral
Vertex Pharmaceuticals (VRTX) Could Be 8% Undervalued Following Raised 2026 Guidance

Vertex Pharmaceuticals (VRTX) has drawn fresh attention after reporting second quarter 2026 results, raising full year revenue guidance to US$13.1b to US$13.2b, and completing a US$1.42b share repurchase program. See our latest analysis for Vertex Pharmaceuticals. The latest updates on guidance and buybacks come after a solid run in Vertex Pharmaceuticals' stock, with a 90 day share price return of 18.19% and a 1 year total shareholder return of 31.48%. This suggests momentum has been...

Is Rockwell Automation (ROK) Stock Too Expensive After Raised Guidance?
Simply Wall St.1d agoneutral
Is Rockwell Automation (ROK) Stock Too Expensive After Raised Guidance?

Rockwell Automation stock has delivered a strong 60.1% return over the past three years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks currently point to the shares trading at a premium. Over the past three years Rockwell Automation has returned 60.1%, which sets a high bar for any further upside to be supported by fundamentals. Recent focus on AI driven quality and automation, including new integrations in its software suite, can support...

Johnson & Johnson (JNJ) Stock Looks Cheap On Cash Flow But Rich On Earnings
Simply Wall St.1d agoneutral
Johnson & Johnson (JNJ) Stock Looks Cheap On Cash Flow But Rich On Earnings

Johnson & Johnson has delivered a 68.9% total return over the past 5 years, yet its valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market multiples lean the other way. Over 5 years, Johnson & Johnson has returned 68.9%, which puts the recent share price near the upper end of its longer term journey. Pipeline progress in areas such as major depressive disorder therapies and new medical technologies like surgical robotics can...

Earnings Prove AI Hardware Demand Is Strong. That’s Good News for Dell Stock.
Barrons.com1d agoneutral
Earnings Prove AI Hardware Demand Is Strong. That’s Good News for Dell Stock.

Dell Technologies stock could have more room to run—even after this year’s meteoric rise—as artificial intelligence hardware demand remains resilient. Wells Fargo analyst Aaron Rakers raised his price target on Dell to $545 from $505 on Friday, which implies a 10% increase from the stock’s last closing price of $494.51. Dell’s “server results and outlook present continued upside,” Rakers wrote in a research note.

Nvidia earnings preview: What’s next for Nvidia stock
Yahoo Finance Video1d agoneutralVIDEO
Nvidia earnings preview: What’s next for Nvidia stock

Yahoo Finance Market and Data Editor Jared Blikre and Senior Business Reporter Ines Ferre join the Executive Editor Brian Sozzi on the Opening Bid panel to preview Nvidia's (NVDA) upcoming earnings and assess what could be next for stock in the weeks ahead.